The latest closing stock price for Blueprint Medicines as of November 22, 2024 is 94.15.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $3,989 today, roughly 4 times their original investment - a 17.44% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 29.5% above the current share price.
The Blueprint Medicines 52-week low stock price is 67.00, which is 28.8% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 93.09.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $3,989 today, roughly 4 times their original investment - a 17.44% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 29.5% above the current share price.
The Blueprint Medicines 52-week low stock price is 67.00, which is 28.8% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 93.09.